In conclusion, GSTs variants were associated with azathioprine efficacy and pharmacokinetics; more studies, both clinical and molecular are still needed to apply this evidence to improve outcomes of therapy with azathioprine in young patients with IBD. Here, HPGDS is linked to inflammatory bowel disease.